Cancer Weekly articles from September 1992

Cancer Weekly archives from September 1992

Improved method for treating leukemia reported. (chronic myeloid leukemia; chemotherapy and bone marrow transplant) (Hahnemann University)
September 7, 1992... Hahnemann University In a study published in the September 1, 1992, issue of the journal Blood, researchers at Hahnemann University, Philadelphia, Pennsylvania; Ohio State University, Columbus, Ohio; St. Vincent's Hospital, Sydney,...

GM-CSF eases aggressive cancer chemotherapy. (granulocyte macrophage colony stimulating factor) (University of New Mexico Cancer Center)
September 7, 1992... University of New Mexico Cancer Center Repeated and unusually intensive doses of chemotherapy can be given to cancer patients more safely, thanks to the drug Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), according to a study...

Free hepatitis B and C blood tests offered to public. (American Liver Foundation)
September 7, 1992... American Liver Foundation Since September 1, 1992, the American Liver Foundation (ALF) has been sponsoring free screenings for hepatitis B and C in 100 cities across the United States. Information on where screenings are being held...

Study indicates silicone triggers specific immune reactions. (University of Texas)
September 7, 1992... University of Texas A new study has revealed antibodies against silicone, a finding supporting speculation that breast implants and other devices can trigger severe illness, investigators said. "This is the first demonstration of...

Breast cancer is being detected at earlier stages. (U.S. National Institutes of Health)
September 7, 1992... U.S. NIH The U.S. National Cancer Institute reports the five-year survival rate for women whose tumors haven't spread beyond the breast is now 92 percent. The rate is 71 percent if the cancer hasn't spread beyond the lymph nodes. ...

Companies start human testing of PEG-Intron drug. (Enzon/Schering Corp.)
September 7, 1992... Enzon/Schering Corp. Enzon Inc., South Plainfield, New Jersey, and Schering Corp., Madison, New Jersey, a subsidiary of Schering-Plough Corp., announced that Phase I human clinical trials have begun on a longer-lasting version of Intron...

Agreement announced for development of genetic tests for prostate cancer. (Oncor Inc., University of Utah)
September 7, 1992... Oncor Inc., University of Utah Oncor Inc., Gaithersburg, Maryland, a manufacturer of DNA probe-based systems for the early detection and management of cancer and other genetic diseases, announced that it has entered into a two-year...

License agreement for tumor research announced. (CytRx Corp., St. Luke's Medical Center)
September 7, 1992... CytRx Corp., St. Luke's Medical Center CytRx Corp., Norcross, Georgia, announced a license agreement with Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, involving certain novel agents that will be developed for the...

Clearance to market CMV-VUE assay received. (test for cytomegalovirus infection) (Incstar Corp.)
September 7, 1992... Incstar Corp. Incstar Corp., Stillwater, Minnesota, announced that it has been given 510(k) clearance by the U.S. Food and Drug Administration to market its new CMV-VUE assay for in vitro diagnostic use. The new assay is a slide...

Dental x-rays found to be safer than previously estimated. (University of California, Los Angeles School of Dentistry)
September 7, 1992... California Dental X-rays are much safer than previously believed, according to a new study by the University of California, Los Angeles (UCLA), School of Dentistry. The study, published in the August 1992 edition of the journal...

New method to deliver anticancer drug. (implanted pump to administer Floxuridine) (Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois)
September 7, 1992... Illinois Rush-Presbyterian-St. Luke's Medical Center (Rush), Chicago, Illinois, is one of nine U.S. sites studying a new way to administer an investigative drug, Floxuridine, to people with advanced kidney cancer. In the new method...

Charges of radar link to cancer growing. (speed detection radar guns) (Washington, D.C.)
September 7, 1992... Washington, D.C. Lawsuits have been filed in five states by police officers who claim their cancers are related to use of speed detection radar guns, but the speed gun manufacturing industry continues to claim the devices pose no health...

Foreign collaboration growing. (U.S. National Cancer Institute)
September 7, 1992... U.S. NCI Less stringent requirements on collaborations with foreign countries has widened the geographic area of study at the U.S. National Cancer Institute (NCI), where researchers will work with heath professionals from 39 countries in...

Joint research & development agreement signed. (Glaxo Inc., Houghten Pharmaceuticals)
September 7, 1992... Glaxo Inc., Houghten Pharmaceuticals Glaxo Inc., Research Triangle Park, North Carolina, and Houghten Pharmaceuticals Inc. (HPI), San Diego, California, announced August 31, 1992, that they have signed a joint research and development...

Cuomo signs bill requiring insurance coverage for Pap smears. (Mario Cuomo) (New York)
September 7, 1992... New York Insurance policies will be required to include coverage for women age 18 and over to have annual tests for cervical cancer, under a bill signed into law by New York Governor Mario Cuomo. Coverage for annual pap smears was...

Controversial ad targets black youth. (anti-smoking advertisement) (New York)
September 7, 1992... New York A controversial anti-smoking advertisement targeting black inner-city youth is being called racist by the tobacco industry. The ad depicts a skeleton in Cowboy garb reminiscent of the Marlboro man lighting a cigarette for a...

Experimental cancer drugs available through Cancer Institute. (East Texas Medical Center)
September 7, 1992... East Texas Medical Center Over 200 cancer patients have participated in experimental drug therapy through East Texas Medical Center's Cancer Institute, Tyler, Texas, said Geneva McClendon, oncology clinical nurse specialist. "We...

Groups release results of public opinion survey on tobacco tax hike. (Michigan) (American Cancer Society, American Lung Association)
September 7, 1992... The American Cancer Society, Michigan Division, Inc., and the American Lung Association of Michigan released results of a public opinion survey September 2, 1992, at a news conference held at the Michigan House of Representatives. ...

New drug treats cancer pain. (Cotar, combination of dipirona, salicilamida and carisoprodol) (Venezuela)
September 7, 1992... An interdisciplinary group of Venezuelan researchers has developed a potent drug capable of combatting the severe pain suffered by terminal cancer patients. The drug, Cotar, is a combination of two anti-pyretic pain-killers and a...

Localized renal allograft irradiation for renal transplant rejection. (Research Report)
September 7, 1992... AUTHORS: Daniel Chin, Kathy T. Howell and Everett K. Spees. University of Colorado Medical Center at Denver. According to the authors' abstract of a poster presentation to the 34th annual meeting of the American Society for Therapeutic...

Therapeutic implications of prolonged treatment with L,S,-buthione sulfoximine. (Research Report)
September 7, 1992... AUTHORS: E.A. Bump, K. Malaker, S. Hurwitz, S.M. Pierce, O.W. Griffith and C.N. Coleman. Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts; Manitoba Cancer Foundation, Winnipeg, Canada; and Cornell University...

A novel method of purging carcinoma contaminated bone marrow, using the lipophilic cation, rhodamine 123. (Research Report)
September 7, 1992... AUTHORS: James R. Wong, Carole Ho, Peter Mauch, Norman Coleman, Stuart Berman and Lan Bo Chen. Harvard Medical School, Boston, Massachusetts. According to the authors' abstract of a poster presentation to the 34th annual meeting of the...

Radiosensitization by etoposide: correlation with a prolonged radiation-induced cell cycle arrest. (Research Report)
September 7, 1992... AUTHORS: Kern J. Minehan, Teresa Christianson and James A. Bonner. Mayo Clinic, Rochester, Minnesota. According to the authors' abstract of a poster presentation to the 34th annual meeting of the American Society for Therapeutic...

3-dimensional dosimetry of head and neck treatment techniques. (Research Report)
September 7, 1992... AUTHORS: G.A. Healey, J.K. Lynch, B.J. DeGaspe, M.D. O'Neil and K.R. Kase. University of Massachusetts Medical Center, Worcester, Massachusetts. According to the authors' abstract of a poster presentation to the 34th annual meeting of...

Prospective study with combined low-dose chemotherapy and zidovudine for 37 patients with poor prognosis HIV-related non-Hodgkin's lymphoma (HIV-NHL). (Research Report)
September 7, 1992... AUTHORS: U. Tirelli, E. Oksenhendler, E. Vaccher, D. Errante, M. Spina, I. Crosato, G. Magnani, A. Malfitano, B. Salassa, F. Lombardi, G. Rizzardini, A. Nosart, G. Ambrosini, G. Rossi, M. Fasan, M. Rizzi, A. Vaglia, G. Angarano and C....

Outcome with central nervous system involvement at diagnosis in childhood acute nonlymphoblastic leukemia. (Research Report)
September 7, 1992... AUTHORS: Parvesh Kumar, Craig A. Hurwitz, Robert A. Krance, Mary A. Rafferty, Dan Ayers and Lary E. Kun. St. Jude's Children's Research Hospital and University of Tennessee College of Medicine, Memphis, Tennessee. According to the...

In vivo testing. (National Cancer Institute research grant announcement) (Research Report)
September 7, 1992... AUTHORS: RFP Available: NCI-CM-37821-12. National Cancer Institute. "Request for Proposals (RFP) Nos. NCI-CM-37821-12 (formerly NCI-CM-37821-28) and NCI-CM-37830-12 will be issued upon written request to Joyce Crooke, Contract...

Biology and immunology of breast cancer: an interdisciplinary approach. (National Cancer Institute research grant announcement) (Research Report)
September 7, 1992... AUTHORS: RFA Available: CA-92-24. National Cancer Institute. "Letter of Intent Receipt Date: November 3, 1992. Application Receipt Date: December 1, 1992. Purpose: The intent of this initiative is to encourage interdisciplinary...

Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. (Periodical Report)
September 7, 1992... SOURCE: The New England Journal of Medicine, August 20, 1992;327(8):516-522. Dacarbazine plus tamoxifen appears to be more effective than dacarbazine alone in the treatment of metastatic melanoma, according to a study by the Italian...

Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. (Periodical Report)
September 7, 1992... SOURCE: Journal of the National Cancer Institute, September 2, 1992;84(17):1336-1341. Cancer cell growth may be regulated by endogenous insulin-like growth factor-binding protein (IGFBP) expression and may be useful as a pharmacologic...

Prognostic factors in survival of bladder cancer. (Periodical Report)
September 7, 1992... SOURCE: Cancer, August 15, 1992;70(4):799-805. Smoking does not appear to represent an important prognostic factor in the survival of patients with bladder cancer, but DNA ploidy, pathologic grade or stage, and the immunohistochemistry...

p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. (Periodical Report)
September 7, 1992... SOURCE: Cancer Research, August 15, 1992;52:4333-4341. Inactivation of the p53 gene through mutations and the allelic deletion may play an important role in gastric cancers, according to a report from Japan's Kobe University School of...

Clinical significance of arginase in colorectal cancer. (Periodical Report)
September 7, 1992... SOURCE: Cancer, August 15, 1992;70(4):733-736. Serum arginase level can be a valuable criterion for preoperative evaluation and possibly postoperative follow-up study in patients with colorectal cancer and can combine with...

Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi's sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. (Periodical Report)
September 7, 1992... SOURCE: Proceedings of the National Academy of Sciences, August 1992;89(15):7046-7050. Kaposi's sarcoma (KS) consists of two types of tumor cells that both have receptors for platelet-derived growth factor (PDGF), in situ studies show....

Emergency teams sampling destroyed palms as sources of new drugs. (palms from the Fairchild Tropical Garden, Miami, damaged by Hurricane Andrew) (U.S. National Cancer Institute)
September 14, 1992... U.S. NCI The U.S. National Cancer Institute (NCI) has sent a research team to Florida in a race to collect samples from a devastated collection of rare palms to search for potential AIDS or cancer drugs, researchers say. Hurricane...

Scientists studying alternative source of taxol. (ornamental yew shrubs) (Ohio State University)
September 14, 1992... Ohio State University In the heart of Ohio dairy country, there's growing hope of finding a new source of the anti-cancer drug taxol. Ohio State University's Ohio Agricultural Research and Development Center (OARDC) has been testing...

Two annual tests are better than one when screening for prostate cancer. (rectal exam and Prostate Specific Antigen test) (Stanford University)
September 14, 1992... Stanford University Prostate cancer, which kills 34,000 U.S. men every year, can be diagnosed earlier and more accurately than ever before with a double set of tests men older than 50 should have once every year, says a Stanford...

Excess weight during middle-age and young adulthood associated with risk of colon cancer. (Harvard School of Public Health)
September 14, 1992... Harvard School of Public Health An ongoing study of alumni from Boston's Harvard University suggests that being overweight during young adulthood is associated with increased risk of colon cancer in inactive men, but overweight men who...

Liver cancer, leukemia incidence high among those exposed to Thorotrast. (radioactive contrast medium) (Denmark)
September 14, 1992... Denmark A Danish study offers further evidence that those exposed to the radioactive colloidal solution Thorotrast, used widely during the 1930s and 1940s, have significantly increased risks of cancers at most sites. The study found...

New treatment option available to cancer patients. (Tumor-Derived Activated Cell Therapy) (Cancer Treatment Centers of America)
September 14, 1992... Cancer Treatment Centers of America A handful of health providers have started introducing a new therapy in which cancer-fighting cells are grown from a patient's own tumor tissue and then reintroduced into the patient's immune system to...

Preliminary data from Phase I/II clinical trial of recombinant thyroid stimulating hormone reported. (U.S. National Institutes of Health)
September 14, 1992... U.S. NIH Preliminary data from a Phase I/II clinical study of recombinant human thyroid stimulating hormone (rhTSH) were released September 2, 1992, in the August 1992 supplemental issue of the journal Thyroid. These data confirm...

Thyroid cancer up dramatically in children near Chernobyl. (Belarus)
September 14, 1992... Belarus Thyroid cancer is occurring at 80 times the normal rate among some children exposed to radioactive fallout from the 1986 explosion at Chernobyl, says a World Health Organization report published September 2, 1992. "We...

Environmental group criticizes Domenici plan to gut drinking water protections. (Senator Pete Domenici) (Natural Resources Defense Council)
September 14, 1992... Natural Resources Defense Council A U.S. Senate proposal to curtail federal regulation of toxic pollutants in the U.S. drinking water supply could result in the exposure of more than 100 million Americans to numerous contaminants...

Companies form global hepatitis vaccine collaboration. (hepatitis E) (Genelabs Technologies, SmithKline Beecham)
September 14, 1992... Genelabs Technologies, SmithKline Beecham Genelabs Technologies Inc. and SmithKline Beecham announced September 3, 1992, the formation of a three-year collaboration for the development and commercialization of a hepatitis E virus vaccine....

Lung cancer surgery mortality examined. (Agency for Health Care Policy and Research)
September 14, 1992... Agency for Health Care Policy and Research Recent findings of lower patient death rates within 30 days of undergoing lung resection for cancer are encouraging. But according to a new study sponsored in part by the Agency for Health Care...

University hospital gets state-of-the-art imaging machine. (Trionix Triple-Headed Gamma Camera) (State University of New York, Stony Brook)
September 14, 1992... State University of New York The University Hospital of the State University of New York at Stony Brook has purchased a new Gamma camera that will help doctors better diagnose and treat stroke, heart disease, cancer and other disorders....

Progress made in effort to obtain FDA approval for oral cancer detection product. (Orascan OTB System) (Zila Pharmaceuticals)
September 14, 1992... Zila Pharmaceuticals Zila Pharmaceuticals Inc., a subsidiary of Zila Inc., reports progress in its efforts to obtain U.S. governmental approval to market the first early detection system for oral cancer. Following a meeting...

Local recurrence versus new primary: a clinical pathological analysis of 82 breast relapses. (Research Report)
September 14, 1992... Local Recurrence versus New Primary: A Clinical AUTHORS: B.G. Haffty, D. Carter, S. Flynn, D. Fischer, D. Brash and J.J. Fischer. Yale University School of Medicine, New Haven, Connecticut. According to the authors' abstract of a...

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. (Research Report)
September 14, 1992... AUTHORS: A. Taghian, J. Ramsay, J. Allalunis-Turner, W. Budach, D. Gioioso, F. Pardo, P. Okunieff, N. Bleehen, R. Urtasun and H. Suit. Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and MCR Unit and...

Radioresponsiveness of human glioma, sarcoma and breast cancer spheroids depends on tumor differentiation. (Research Report)
September 14, 1992... AUTHORS: Martin Stuschke, Volker Budach and Horst Sack. University of Essen, Essen, Germany. According to the authors' abstract of a poster presentation to the 34th annual meeting of the American Society for Therapeutic Radiology and...

Performance status of long term disease free survivors of intracranial gliomas. (Research Report)
September 14, 1992... AUTHORS: Lawrence Kleinberg, Mark Malkin and Kent Wallner. Memorial Sloan-Kettering Cancer Center, New York, New York. According to the authors' abstract of a poster presentation to the 34th annual meeting of the American Society for...

Computer-aided geometric reconstruction of Fletcher-Suit source positions. (Research Report)
September 14, 1992... AUTHORS: S. Li, C.A. Pelizzari, C. Reft, H.G. Sutton and G.T.Y. Chen. University of Chicago Center for Radiation Therapy, Chicago, Illinois. According to the authors' abstract of a poster presentation to the 34th annual meeting of the...

Possible role of metallothionein in carcinogenesis. (National Cancer Institute research grant announcement) (Research Report)
September 14, 1992... AUTHORS: RFA Available: CA-92-22. National Cancer Institute. "Letter of Intent Receipt Date: October 2, 1992. Application Receipt Date: December 8, 1992. Purpose: The Chemical and Physical Carcinogenesis Branch, Division of Cancer...

Biomarkers of dietary fat in post-menopausal women. (National Cancer Institute research grant announcement) (Research Report)
September 14, 1992... AUTHORS: RFA Available: CA-92-14. National Cancer Institute. "Letter of Intent Receipt Date: October 7, 1992. Application Receipt Date: January 26, 1993. Purpose: The Division of Cancer Prevention and Control, National Cancer...

Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. (Periodical Report)
September 14, 1992... SOURCE: Journal of Radiation Oncology, Biology and Physics, August, 1992;24(1):3-9. Radical radiation therapy is an effective treatment for non-small-cell tumors of the lung when doses of 65 Gy or more are used, according to a report...

Randomized controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma. (Periodical Report)
September 14, 1992... SOURCE: The Lancet, August 29, 1992;340:502-507. Patients with stage III lymph node-positive colorectal cancers appear to perform better when treated with surgery plus chemotherapy with fluorouracil plus heparin than those treated with...

The use of ondansetron in patients receiving multiple-day cisplatin regimens. (Periodical Report)
September 14, 1992... SOURCE: Seminars in Oncology, August, 1992;4(10):48-52. The antiemetic ondansetron appears to be safe, active and well tolerated when used as a single agent in the control of nausea and vomiting in patients receiving multiple-day...

Association between brain tumors and menopausal status. (Periodical Report)
September 14, 1992... SOURCE: Journal of the National Cancer Institute, September 2, 1992;84(17):1346-1349. A German study examining the association between brain tumors and menopausal status adds evidence to the view that hormones play a role in brain tumor...

Thymopentin in Sezary syndrome. (Periodical Report)
September 14, 1992... SOURCE: Journal of the National Cancer Institute, September 2, 1992;84(17):1341-1346. The synthetic pentapeptide thymopentin (TP-5) is a potentially useful agent in the treatment of a subgroup of patients with the lymphoma known as...

Effectiveness in disease and injury prevention, public health focus: effectiveness of smoking-control strategies - United States. (Periodical Report)
September 14, 1992... SOURCE: Morbidity and Mortality Weekly Report, September 4, 1992. "In 1990, approximately 46 million adults in the United States continued to smoke; however, more than 44 million persons were former smokers who had reduced their risk for...

New contraceptive may prevent breast cancer. (injectable gonadotropin-releasing hormone agonist, GnRHA) (University of Southern California)
September 21, 1992... University of Southern California Preliminary results have been encouraging in a pilot trial of a new form of contraceptive designed to prevent breast and ovarian cancers, according to research to be presented September 22, 1992, at a...

Taxol production capacity at new facility to increase. (Hauser Chemical Research Inc.)
September 21, 1992... Hauser Chemical Research Hauser Chemical Research Inc., Boulder, Colorado, announced that it has been requested by Bristol-Myers Squibb Co. to increase the capacity of its new taxol processing facility from 100 kilograms of taxol per...

Blood test may predict lung cancer. (identification of DNA adducts) (Columbia University)
September 21, 1992... Columbia University A novel blood test under investigation by Columbia University researchers may predict who will get lung cancer, according to researchers. According to statistics, one out of ten smokers will develop lung cancer....

New program evaluates individual's genetic risk for cancer. (University of Chicago Medical Center)
September 21, 1992... Illinois A new program at the University of Chicago Medical Center has been established to evaluate and care for individuals and families who are currently healthy but may be at increased risk for cancer. More than one million...

Lung cancer risk doubles in nonsmoking women exposed to passive smoke. (University of South Florida)
September 21, 1992... University of South Florida Long-term exposure to environmental tobacco smoke can more than double the risk of lung cancer in women who have never smoked, according to researchers at the University of South Florida, Tampa, Florida. ...

New campaign could encourage children to smoke. (tobacco industry campaigns evaluated by Dr. Joseph R. DiFranza) (Massachusetts)
September 21, 1992... Massachusetts A tobacco industry campaign to discourage children from smoking actually encourages youngsters to light up by portraying cigarettes as "forbidden fruit," a researcher says. The program, called "Tobacco: Helping Youth...

All-out war on smoking squeezes tobacco industry. (Australia)
September 21, 1992... Australia Australian tobacco firms are turning to overseas markets as the country goes all-out in its anti-smoking drive with bans on cigarette advertising and huge compensations for smoke-related illnesses. Over the past 18 months,...

Phenylacetate may aid in treatment of cancer. (U.S. National Cancer Institute)
September 21, 1992... U.S. NCI A nontoxic drug commonly used to treat children with inherited urea cycle disorders may also be beneficial in treating certain inherited blood diseases and possibly cancer, according to researchers from the U.S. National Cancer...

Boron neutron capture therapy animal studies show increased survival rates. (New England Medical Center)
September 21, 1992... New England Medical Center Researchers have found that when Boron Neutron Capture Therapy (BNCT) radiation therapy was used on mice with brain tumors, the survival of the mice was extended by up to 260 percent when compared to mice...

Researchers report on interleukin-2 and other biologic approaches to treating cancer. (New England Medical Center)
September 21, 1992... New England Medical Center Researchers in Boston, Massachusetts, and Bethesda, Maryland, report that Interleukin-2 and other biologic approaches to treating cancer are gaining in use and effectiveness. In the forward to a new book,...

Research indicates GM-CSF eases aggressive cancer chemotherapy. (granulocyte macrophage colony stimulating factor) (University of New Mexico)
September 21, 1992... New Mexico Supplementation of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) safely allows for repeated and intense doses of chemotherapy, according to a study conducted at the University of New Mexico (UNM) Cancer Center,...

Establishment of minority research centers announced. (U.S. Department of Health and Human Services)
September 21, 1992... U.S. HHS U.S. Department of Health and Human Services (HHS) Secretary Louis W. Sullivan, M.D., announced the establishment of six federally funded research centers in New York, New York; San Antonio, Texas; Los Angeles, California;...

Orphan drug designation for hepatitis-B treatment granted. (fialuridine) (U.S. Food and Drug Administration)
September 21, 1992... U.S. FDA Oclassen Pharmaceuticals Inc., San Rafael, California, announced that it has received an Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for fialuridine (FIAU), an oral antiviral compound that has shown...

Global hepatitis vaccine collaboration formed. (hepatitis E) (Genelabs Technologies/SmithKline Beecham)
September 21, 1992... Genelabs Technologies/SmithKline Beecham Genelabs Technologies Inc., Redwood City, California, and SmithKline Beecham, Philadelphia, Pennsylvania, announced the formation of a three-year collaboration for the development and...

Seventy percent of respondents in poll favor product labeling. (potential carcinogens) (Ohio)
September 21, 1992... Ohio Seven out of 10 Ohioans surveyed in a newspaper poll approved of a ballot issue that would require products that may cause cancer to carry warning labels. The Columbus Dispatch reported September 8, 1992, that 70 percent of...

Synthesis of chemical modifiers of radiation response. (National Cancer Institute research grant announcement) (Research Report)
September 21, 1992... AUTHORS: RFP Available: NCI-CM-37828-75. National Cancer Institute. "The Radiotherapy Development Branch, Radiation Research Program, Division of Cancer Treatment, National Cancer Institute is seeking organizations with the capability...

Quality of life assessment in special populations. (National Cancer Institute, National Center for Nursing Research research grant announcement) (Research Report)
September 21, 1992... AUTHORS: RFA Available: CA/NR-92-27. National Cancer Institute, National Center for Nursing Research. "Letter of Intent Receipt Date: October 23, 1992. Application Receipt Date: January 19, 1993. Purpose: The National Cancer...

Predictors of survival after a positive post-irradiation prostate biopsy. (Research Report)
September 21, 1992... AUTHORS: Bradley R. Prestidge, Irving Kaplan, Richard S. Cox and Malcolm A. Bagshaw. Stanford University Medical Center, Stanford, California. According to the authors' abstract of a poster presentation to the 34th annual meeting of...

Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. (Research Report)
September 21, 1992... AUTHORS: Luis Souhami, Robert Seymour, Ted Roman, Gerald Stanimir, Marc Trudeau, Carolyn Freeman and Brenda Clark. McGill University, Montreal, Canada. According to the authors' abstract of a poster presentation to the 34th annual...

PSA doubling times in patients with prostate cancer, a potentially useful reflection of tumor doubling time. (prostate specific antigen) (Research Report)
September 21, 1992... AUTHORS: Gerald E. Hanks, Barry E. Epstein, Ruth Peter and Timothy E. Schultheiss. Fox Chase Cancer Center, Philadelphia, Pennsylvania. According to the authors' abstract of a poster presentation to the 34th annual meeting of the...

Analysis of the 3-D treatment planning process: 750 patients clinically planned in 1991. (Research Report)
September 21, 1992... AUTHORS: B.A. Fraass, D.L. McShan, B.R. Yanke, G.M. Matrone and A.S. Lichter. University of Michigan Medical Center, Ann Arbor, Michigan. According to the authors' abstract of a poster presentation to the 34th annual meeting of the...

Radiobiologic basis of lymphoma radio-immunotherapy. (Research Report)
September 21, 1992... AUTHORS: Roger M. Macklis, Beverly Beresford, Robert Atcher, Siobhan Sweeney, Sanjoo Palayoor and John L. Humm. Harvard Medical School, Boston, Massachusetts, and Argonne National Laboratory, Argonne, Illinois. According to the...

No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology. (Periodical Report)
September 21, 1992... SOURCE: Journal of Clinical Oncology, September, 1992;10(9):1407-1412. The addition of ifosfamide to a chemotherapeutic regimen did not improve the treatment outcome of a group of patients with Ewing's sarcoma in a nonrandomized French...

Radiosurgery as part of the initial management of patients with malignant gliomas. (Periodical Report)
September 21, 1992... SOURCE: Journal of Clinical Oncology, September 1992;10(9):1379-1385. Radiosurgery is a useful adjunct to other treatments in the initial management of patients with small, radiographically well-defined malignant gliomas, according to a...